ALK-Abelló Investor Relations Material
Latest events
Q4 2023
ALK-Abelló
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from ALK-Abelló
Access all reports
Segment Data
Access more data
Revenue by
Business area
SLIT-tablets
SCIT/SLIT-drops
Other products and services
Expenses by
Financials
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company produces test kits for allergy and asthma assessment; allergy alert systems; blood pressure monitors; clinical chemistry analyzers; immunoassays and biochemistry instruments, Bruker X-ray fluorescence spectrometers, and various other products. It also provides allergy diagnostic solutions, including skin testing systems; test kits to identify urushiols that cause natural rubber allergies; laboratory equipment to measure patient serum samples suspected of having restricted proteins; a compact EDM device that helps dermatologists treat contact dermatitis via electromagnetic healing vibrations; a patch test panel to help prevent hospital patients from developing hypersensitivity and subsequent allergies during their stay; a test kit for the identification of contact urticaria triggered by nickel based alloys used in jewellery making and dental implants.
Key slides for ALK-Abelló
Q4 2023
ALK-Abelló
Q4 2023
ALK-Abelló
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇩🇰 Denmark